MAY 20, 2020
11:15 AM EDT | APAC MAY 21, 2020 2:15 PM CST
Metastatic prostate cancer (mPC) is a phenotypically diverse disease with poor responses to immune based therapeutics. Development of immunotherapeutic strategies for mPC is hampered by the...